Evidence map›Paper›PMID 27601972›Full record

ArticleReviews in urology2016

Tubulocystic Renal Cell Carcinoma: A Great Imitator.

Indraneel Banerjee, Sher Singh Yadav, Vinay Tomar, Suresh Yadav, Shyam Talreja

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Reviews in urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Tubulocystic Renal Cell Carcinoma in Young Adult.Indian journal of surgical oncology · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.Radiographics : a review publication of the Radiological Society of North America, Inc
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Indraneel BanerjeeDepartment of Urology, Sawai Man Singh Medical College and Hospital Jaipur, India.
Sher Singh YadavDepartment of Urology, Sawai Man Singh Medical College and Hospital Jaipur, India.
Vinay TomarDepartment of Urology, Sawai Man Singh Medical College and Hospital Jaipur, India.
Suresh YadavDepartment of Urology, Sawai Man Singh Medical College and Hospital Jaipur, India.
Shyam TalrejaDepartment of Urology, Sawai Man Singh Medical College and Hospital Jaipur, India.
SMS Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulocystic renal cell carcinoma (TCRC) is a rare renal tumor. Patients are usually asymptomatic; it is usually detected incidentally, during imaging studies for Bosniak type III and type IV renal cysts. These tumors rarely metastasize. The role of targeted therapy in such rare tumors is still controversial. We report a case of TCRC initially presented as a Bosniak type II renal cyst and was discovered ultimately to be a metastatic disease. This type of presentation might broaden our understanding of this rare disease.

Indexed as

Bosniak type II cystTargeted therapyTubulocystic renal cell carcinoma

Identifiers

PMID27601972
PMCPMC5010634
OpenAlexW2529982740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.